WHERE ARE YOU?
A sister publication of MedDeviceCyber.com
Saturday, September 5, 2026
Updated every morning. Free. No login.
THE TAPE
Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register
The Directory // Manufacturing, Components & Supply

Manufacturing, Components & Supply

Contract manufacturers, components, materials and packaging. 1 companies listed.

Richmond, TX  ·  Est. 2012  ·  Unknown

Contract design and manufacturing firm for active therapeutic and diagnostic devices whose services include embedded cybersecurity, secure firmware development and automated test systems. Known for helping scale ventilator production with General Motors in 2020.

One email, every morning
THE MORNING BRIEF

New clearances, funding rounds and regulatory moves for device founders. No noise, no login.

You're in. The next morning brief lands in your inbox.

Unsubscribe anytime. We never sell the list.